National Quality Awards 2024 (NQA 2024) Winner – UK German Pharmaceuticals

The National Quality Awards (NQA) 2024 – 2nd Edition, organized by Brand Empower at the grand Seven Seas Hotel, New Delhi, celebrated individuals and companies who set benchmarks of excellence. The evening was marked by Padma Shri Mrs. Raveena Tandon as the Guest of Honor. Powered by our esteemed partners – Digital Marketing Partner: Webpulse Solution Pvt. Ltd. and CSR Partner: Webpulse Foundation – the event recognized true leaders shaping industries. Among the awardees, Mr. Upkar Kansal was honored with the title “Result-Oriented Diabetic Medicines Brand in India”, highlighting his significant contribution.

Award Recognition – Result-Oriented Diabetic Medicines Brand in India

The recognition of Mr. Upkar Kansal with the title “Result-Oriented Diabetic Medicines Brand in India” at NQA 2024 showcases his brand’s remarkable achievements in pharmaceutical innovation and trust. This award acknowledges his efforts in creating solutions that have positively impacted countless lives, reinforcing the importance of quality, reliability, and consistent results in healthcare. By honoring Mr. Kansal, the National Quality Awards emphasize how his work reflects excellence in research-driven pharmaceutical products and the delivery of tangible results. The award validates his commitment to innovation and underlines the vital role of responsible leadership in shaping the future of healthcare in India.

About Mr. Upkar Kansal & UK German Pharmaceuticals

Mr. Upkar Kansal, representing UK German Pharmaceuticals, has built a brand known for quality and trust in the pharmaceutical sector. Established in 1991 under the leadership of Dr. Bhim Sain Kansal, the company has been a pioneer in delivering effective healthcare solutions, particularly in animal pharmaceuticals. Today, UK German Pharmaceuticals is recognized for its advanced research, diverse product range, and strict adherence to quality standards. Their formulations, spanning vaccines, antibiotics, and supplements, have gained national recognition. With Mr. Kansal’s vision and leadership, the company continues to bridge innovation with reliability, making its award at NQA 2024 both timely and well-deserved.